The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-5-methyl-2-(5-methylisoxazol-3-yl)furan-3-carboxamide
ID: ALA4454486
PubChem CID: 155524035
Max Phase: Preclinical
Molecular Formula: C20H23N3O3
Molecular Weight: 353.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2cc(C)oc2-c2cc(C)on2)cc1
Standard InChI: InChI=1S/C20H23N3O3/c1-5-23(6-2)16-9-7-15(8-10-16)21-20(24)17-11-13(3)25-19(17)18-12-14(4)26-22-18/h7-12H,5-6H2,1-4H3,(H,21,24)
Standard InChI Key: ODEKNMDFMSYWJO-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
30.6531 -18.6513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.6470 -19.4684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4217 -19.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9088 -19.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4317 -18.4070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6885 -17.6286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4674 -17.3815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4732 -16.5643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6977 -16.3063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2128 -16.9641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1808 -16.1558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7260 -19.0742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1304 -19.7843 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9475 -19.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3495 -20.4984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1660 -20.5037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5796 -19.7979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1709 -19.0854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3558 -19.0836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3968 -19.8017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8021 -20.5113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6193 -20.5151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8087 -19.0959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6259 -19.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1388 -18.3689 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9393 -19.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 6 2 0
8 11 1 0
4 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
12 25 2 0
2 26 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.42 | Molecular Weight (Monoisotopic): 353.1739 | AlogP: 4.65 | #Rotatable Bonds: 6 |
Polar Surface Area: 71.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.43 | CX LogP: 3.74 | CX LogD: 3.74 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.70 | Np Likeness Score: -1.63 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |